Literature DB >> 25866272

Aptamers: molecular tools for medical diagnosis.

Veli Cengiz Ozalp1, Murat Kavruk, Ozlem Dilek, Abdullah Tahir Bayrac.   

Abstract

Aptamers have been increasingly applied in biomedical field as a class of biorecognition elements that possess many advantages such as high specificity and binding affinity, easy synthesis, easy modification, small size, non-toxicity and good stability. Many diseases like cancer exhibit cellular aberrations at morphological and molecular levels. Medical diagnosis based on molecular features can be highly specific and extremely sensitive when proper recognition molecule and an efficient signal transduction system are employed. However, bioanalysis of human diseases at the molecular level is an extremely challenging field because effective probes to identify and recognize biomarkers of diseases are not readily available. Traditional bio-recognition molecule, antibody has been exploited to develop excellent diagnosis assays in many formats, but antibodies are insufficient to match the requirements of fast and portable biosensors for point-of-care applications, which are at high demand in pathogenic bacteria detection as well as other diseases like cancer. Aptamers are short single-stranded oligonucleotides, which can be selected from random combinatorial library by SELEX in vitro. This relatively new biorecognition agent has superior intrinsic characteristics for biosensor development. In this review, we first present major aptamer selection technologies and the main formats of biosensors, which were frequently employed in aptasensor development. Then, the current state of aptamers as applied to medical diagnosis was discussed for specifically cancer and pathogen diagnosis. Finally, an overview of aptamer-nanomaterials conjugates was presented in many applications such as diagnosis, bioimaging, and theranostics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25866272     DOI: 10.2174/1568026615666150413154233

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  16 in total

1.  Automated selection of aptamers against cholangiocarcinoma cells on an integrated microfluidic platform.

Authors:  Priya Gopinathan; Lien-Yu Hung; Chih-Hung Wang; Nai-Jung Chiang; Yu-Chun Wang; Yan-Shen Shan; Gwo-Bin Lee
Journal:  Biomicrofluidics       Date:  2017-07-05       Impact factor: 2.800

2.  Selective recognition of c-MYC Pu22 G-quadruplex by a fluorescent probe.

Authors:  Qianqian Zhai; Chao Gao; Jieqin Ding; Yashu Zhang; Barira Islam; Wenxian Lan; Haitao Hou; Hua Deng; Jun Li; Zhe Hu; Hany I Mohamed; Shengzhen Xu; Chunyang Cao; Shozeb M Haider; Dengguo Wei
Journal:  Nucleic Acids Res       Date:  2019-03-18       Impact factor: 16.971

Review 3.  [Research advances in the role of aptamers in the diagnosis and targeted therapy of pediatric cancer].

Authors:  Yi-Bin Zhang; Yan-Peng Wang; Jing Liu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-05

4.  Inhibitory effects of aptamer targeted teicoplanin encapsulated PLGA nanoparticles for Staphylococcus aureus strains.

Authors:  Samet Ucak; Mert Sudagidan; Baris A Borsa; Banu Mansuroglu; Veli C Ozalp
Journal:  World J Microbiol Biotechnol       Date:  2020-04-25       Impact factor: 3.312

5.  Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in Melanomas.

Authors:  David Kryza; Frédéric Debordeaux; Laurent Azéma; Aref Hassan; Olivier Paurelle; Jürgen Schulz; Catherine Savona-Baron; Elsa Charignon; Pauline Bonazza; Jacqueline Taleb; Philippe Fernandez; Marc Janier; Jean Jacques Toulmé
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

Review 6.  MIPs and Aptamers for Recognition of Proteins in Biomimetic Sensing.

Authors:  Marcus Menger; Aysu Yarman; Júlia Erdőssy; Huseyin Bekir Yildiz; Róbert E Gyurcsányi; Frieder W Scheller
Journal:  Biosensors (Basel)       Date:  2016-07-18

7.  Efficient functional neutralization of lethal peptide toxins in vivo by oligonucleotides.

Authors:  Tarek Mohamed Abd El-Aziz; Corinne Ravelet; Jordi Molgo; Emmanuelle Fiore; Simon Pale; Muriel Amar; Sawsan Al-Khoury; Jérôme Dejeu; Mahmoud Fadl; Michel Ronjat; Germain Sotoing Taiwe; Denis Servent; Eric Peyrin; Michel De Waard
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

Review 8.  Aptamer Therapeutics in Cancer: Current and Future.

Authors:  Yoshihiro Morita; Macall Leslie; Hiroyasu Kameyama; David E Volk; Takemi Tanaka
Journal:  Cancers (Basel)       Date:  2018-03-19       Impact factor: 6.639

9.  Antibiotic administration in targeted nanoparticles protects the faecal microbiota of mice.

Authors:  Baris A Borsa; Mert Sudagidan; Mehmet E Aldag; Isik I Baris; Elif E Acar; Cagatay Acuner; Murat Kavruk; Veli C Ozalp
Journal:  RSC Med Chem       Date:  2021-01-15

Review 10.  Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.

Authors:  Rusdina Bte Ladju; Devis Pascut; Muhammad Nasrum Massi; Claudio Tiribelli; Caecilia H C Sukowati
Journal:  Oncotarget       Date:  2017-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.